Goldman Sachs’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.3K | Sell |
14,678
-47,041
| -76% | -$107K | ﹤0.01% | 5015 |
|
|
2025
Q1 | $39.2K | Buy |
+61,719
| New | +$39.2K | ﹤0.01% | 4940 |
|
|
2024
Q4 | – | Sell |
-12,000
| Closed | -$14.2K | – | 5043 |
|
|
2024
Q3 | $14.2K | Sell |
12,000
-97,302
| -89% | -$115K | ﹤0.01% | 4719 |
|
|
2024
Q2 | $133K | Sell |
109,302
-184,592
| -63% | -$225K | ﹤0.01% | 4459 |
|
|
2024
Q1 | $641K | Buy |
+293,894
| New | +$641K | ﹤0.01% | 3864 |
|
|
2023
Q3 | – | Sell |
-10,217
| Closed | -$17.6K | – | 4762 |
|
|
2023
Q2 | $17.6K | Sell |
10,217
-3,180
| -24% | -$5.47K | ﹤0.01% | 4767 |
|
|
2023
Q1 | $20.2K | Sell |
13,397
-90,527
| -87% | -$137K | ﹤0.01% | 4882 |
|
|
2022
Q4 | $166K | Sell |
103,924
-29,769
| -22% | -$47.6K | ﹤0.01% | 4556 |
|
|
2022
Q3 | $194K | Sell |
133,693
-53,849
| -29% | -$78.1K | ﹤0.01% | 4736 |
|
|
2022
Q2 | $343K | Sell |
187,542
-571,047
| -75% | -$1.04M | ﹤0.01% | 4615 |
|
|
2022
Q1 | $2.03M | Buy |
758,589
+121,643
| +19% | +$325K | ﹤0.01% | 3578 |
|
|
2021
Q4 | $2.76M | Sell |
636,946
-472,119
| -43% | -$2.04M | ﹤0.01% | 3264 |
|
|
2021
Q3 | $5.65M | Buy |
1,109,065
+157,048
| +16% | +$799K | ﹤0.01% | 2700 |
|
|
2021
Q2 | $6.03M | Buy |
952,017
+742,915
| +355% | +$4.7M | ﹤0.01% | 2644 |
|
|
2021
Q1 | $1.62M | Sell |
209,102
-18,347
| -8% | -$142K | ﹤0.01% | 3552 |
|
|
2020
Q4 | $1.49M | Sell |
227,449
-52,374
| -19% | -$343K | ﹤0.01% | 3234 |
|
|
2020
Q3 | $1.86M | Buy |
279,823
+1,978
| +0.7% | +$13.2K | ﹤0.01% | 2947 |
|
|
2020
Q2 | $2.32M | Buy |
277,845
+139,797
| +101% | +$1.16M | ﹤0.01% | 2767 |
|
|
2020
Q1 | $1.06M | Sell |
138,048
-262,407
| -66% | -$2.01M | ﹤0.01% | 3083 |
|
|
2019
Q4 | $3.33M | Buy |
400,455
+11,725
| +3% | +$97.4K | ﹤0.01% | 2655 |
|
|
2019
Q3 | $2.87M | Sell |
388,730
-17,627
| -4% | -$130K | ﹤0.01% | 2648 |
|
|
2019
Q2 | $4.56M | Buy |
406,357
+208,982
| +106% | +$2.34M | ﹤0.01% | 2346 |
|
|
2019
Q1 | $2.12M | Sell |
197,375
-300,717
| -60% | -$3.23M | ﹤0.01% | 2915 |
|
|
2018
Q4 | $7.52M | Buy |
498,092
+42,039
| +9% | +$635K | ﹤0.01% | 2071 |
|
|
2018
Q3 | $8.44M | Sell |
456,053
-65,055
| -12% | -$1.2M | ﹤0.01% | 2148 |
|
|
2018
Q2 | $11.9M | Buy |
521,108
+102,216
| +24% | +$2.34M | ﹤0.01% | 1907 |
|
|
2018
Q1 | $11.9M | Sell |
418,892
-38,727
| -8% | -$1.1M | ﹤0.01% | 1829 |
|
|
2017
Q4 | $9.66M | Buy |
457,619
+132,454
| +41% | +$2.8M | ﹤0.01% | 1920 |
|
|
2017
Q3 | $5.91M | Buy |
325,165
+197,389
| +154% | +$3.59M | ﹤0.01% | 2250 |
|
|
2017
Q2 | $1.98M | Buy |
127,776
+116,794
| +1,064% | +$1.81M | ﹤0.01% | 2815 |
|
|
2017
Q1 | $190K | Buy |
+10,982
| New | +$190K | ﹤0.01% | 3969 |
|
|
2016
Q1 | – | Sell |
-15,278
| Closed | -$319K | – | 4502 |
|
|
2015
Q4 | $319K | Buy |
+15,278
| New | +$319K | ﹤0.01% | 3480 |
|